---
title: "SLAMON DENNIS — Ownership Dossier"
canonical: https://whiteintel.dev/entity/be0703c5-8b17-5b26-bb8a-fdc0e22d3703
json: https://whiteintel.dev/api/public/dossier/be0703c5-8b17-5b26-bb8a-fdc0e22d3703
identifier: sec:0001603265
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# SLAMON DENNIS

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001603265`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/be0703c5-8b17-5b26-bb8a-fdc0e22d3703  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/be0703c5-8b17-5b26-bb8a-fdc0e22d3703  

## Ownership & control

### Holdings / subsidiaries

- **BIOMARIN PHARMACEUTICAL INC** (director) — https://whiteintel.dev/entity/da243f5f-5fb4-5808-b258-c3726f1bb8cb

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **SLAMON DENNIS**. Human view: https://whiteintel.dev/entity/be0703c5-8b17-5b26-bb8a-fdc0e22d3703 · Structured JSON: https://whiteintel.dev/api/public/dossier/be0703c5-8b17-5b26-bb8a-fdc0e22d3703._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._